ZA947825B - Stem cell proliferation factor. - Google Patents

Stem cell proliferation factor.

Info

Publication number
ZA947825B
ZA947825B ZA947825A ZA947825A ZA947825B ZA 947825 B ZA947825 B ZA 947825B ZA 947825 A ZA947825 A ZA 947825A ZA 947825 A ZA947825 A ZA 947825A ZA 947825 B ZA947825 B ZA 947825B
Authority
ZA
South Africa
Prior art keywords
stem cell
cell proliferation
cells
growth
scpf
Prior art date
Application number
ZA947825A
Other languages
English (en)
Inventor
Michael J P Lawman
Patricia D Lawman
Nancy D Denslow
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of ZA947825B publication Critical patent/ZA947825B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA947825A 1993-10-06 1994-10-06 Stem cell proliferation factor. ZA947825B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13299493A 1993-10-06 1993-10-06

Publications (1)

Publication Number Publication Date
ZA947825B true ZA947825B (en) 1995-08-22

Family

ID=22456541

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA947825A ZA947825B (en) 1993-10-06 1994-10-06 Stem cell proliferation factor.

Country Status (10)

Country Link
US (2) US5650299A (de)
EP (1) EP0724632B1 (de)
JP (2) JP3253966B2 (de)
AT (1) ATE274577T1 (de)
AU (1) AU691529B2 (de)
CA (1) CA2173592C (de)
DE (1) DE69433967D1 (de)
IL (1) IL111181A0 (de)
WO (1) WO1995009912A1 (de)
ZA (1) ZA947825B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009912A1 (en) * 1993-10-06 1995-04-13 University Of Florida Research Foundation, Inc. Stem cell proliferation factor
US5945403A (en) * 1997-05-30 1999-08-31 The Children's Medical Center Corporation Angiostatin fragments and method of use
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
US5928638A (en) * 1996-06-17 1999-07-27 Systemix, Inc. Methods for gene transfer
US5948426A (en) * 1997-05-03 1999-09-07 Jefferies; Steven R. Method and article to induce hematopoietic expansion
AU9200398A (en) * 1997-08-22 1999-03-16 Yale University A process to study changes in gene expression in granulocytic cells
DK1151300T3 (da) * 1998-12-23 2010-07-12 Medsaic Pty Ltd Assay til påvisning af en bindingspartner
EP1016413A1 (de) * 1998-12-30 2000-07-05 Applied Research Systems ARS Holding N.V. Menschliches Wachstumshormon (HGH) zur Stimulierung der Mobilisierung pluripotenter Hämatopoietischer Stammzellen
US6680208B1 (en) * 1999-11-19 2004-01-20 Becton, Dickinson And Company Rapid protein identification using antibody mixtures
EP1302203A4 (de) * 2000-07-18 2004-01-14 Nichimo Kk Verstärkungsmaterial für stammzellen
CN1373216A (zh) * 2001-02-28 2002-10-09 中国医学科学院阜外心血管病医院 肌细胞增殖抑制因子Fwa267
CN1373217A (zh) * 2001-02-28 2002-10-09 中国医学科学院阜外心血管病医院 细胞增殖因子Fwap10576
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
US7268229B2 (en) * 2001-11-02 2007-09-11 Promega Corporation Compounds to co-localize luminophores with luminescent proteins
AU2003243273A1 (en) * 2002-05-22 2003-12-12 Biogen Idec Ma Inc. Detection of secreted polypeptides
CA2508690A1 (en) * 2002-12-10 2004-06-24 Ottawa Health Research Institute Modulation of stem cell differentiation by modulation of caspase-3 activity
EP2079832A4 (de) * 2006-05-17 2010-08-04 Cognate Therapeutics Inc Isolierung und aufreinigung hämatopoetischer stammzellen aus lipoaspirat nach fettabsaugung
WO2008039874A2 (en) 2006-09-26 2008-04-03 Cedars-Sinai Medical Center Cancer stem cell antigen vaccines and methods
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN109415696A (zh) 2016-05-25 2019-03-01 泰尔茂比司特公司 细胞扩增
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
EP3601521A2 (de) 2017-03-31 2020-02-05 Terumo BCT, Inc. Zellexpansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105324A0 (en) * 1992-04-06 1993-08-18 Univ Florida Stem cell proliferation factor
US6228609B1 (en) * 1992-07-09 2001-05-08 Systemix, Inc. Soluble Flk-2 sequence
WO1995009912A1 (en) * 1993-10-06 1995-04-13 University Of Florida Research Foundation, Inc. Stem cell proliferation factor

Also Published As

Publication number Publication date
EP0724632A4 (de) 1999-01-07
AU7929994A (en) 1995-05-01
EP0724632A1 (de) 1996-08-07
EP0724632B1 (de) 2004-08-25
CA2173592A1 (en) 1995-04-13
WO1995009912A1 (en) 1995-04-13
AU691529B2 (en) 1998-05-21
JP3253966B2 (ja) 2002-02-04
JPH09506245A (ja) 1997-06-24
JP2002155100A (ja) 2002-05-28
IL111181A0 (en) 1994-12-29
US5650299A (en) 1997-07-22
ATE274577T1 (de) 2004-09-15
CA2173592C (en) 2007-09-25
DE69433967D1 (de) 2004-09-30
US5981708A (en) 1999-11-09

Similar Documents

Publication Publication Date Title
ZA947825B (en) Stem cell proliferation factor.
EP0670369A3 (de) An menschliches programmiertes Zelltod relatiertes Peptid, und dessen kodierende DNA
MX9706827A (es) Activacion de receptor por gas6.
EP0216742A3 (de) Wachstumsfaktoren
EP0833912A4 (de) Neues tgf-beta-ahnliches cytokin
UA81398C2 (en) Keratinocytes which may be used as biologically active substances for the treatment of wounds
HK1004150A1 (en) Calcium free subtilisin mutants.
MX9700818A (es) Produccion bacteriana de polipeptidos hidrofobicos.
EP0824545A4 (de) Peptidverbindungen mit wachstumsfaktorähnlicher aktivität
ATE227739T1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
GR940300052T1 (en) Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms.
IL160338A0 (en) Method of protein production in plants
WO2002030958A3 (de) Casein-peptidfragmente mit wachstumsbeeinflussender aktivität auf zellkulturen
AU1384995A (en) Human circulating cytokine cc-1
HU895788D0 (en) Process for producing peptides and medical products containing them
KR100256319B1 (en) Stem cell proliferation factor
AU2534595A (en) Angiotensin ii for improving fertilization
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
NZ333412A (en) Plant proteins treated to reduce isoflavones, manganese and nucleotides and nutritional products made therefrom
NZ307579A (en) Recombinant preduodenal lipases and polypeptides derivatives produced by plants, processes for obtaining them and their uses
SE9401380D0 (sv) Ny celltillväxt-relaterad peptid och användning därav
ES2018726A6 (es) Procedimiento para preparar derivdos de mitomicina.
AU1305097A (en) Protein induced by deprenyl$m(3)
CA2329273A1 (en) Method for transforming plant, the resultant plant and gene thereof
WO1994021273A3 (de) VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN